Table 3 PICOS table
| P |
Refugees[40] Asylum seekers[40] Migrant hard-to-reach populations[41] Living in the geographical territory of OECD[42], EU[43], EEA[45] and EU-applicant [46] countries | |||
| I | All interventions targeting to lower incidence, prevalence, transmission, or mortality of one or more of the following respiratory infections: | |||
| Upper respiratory infections | Lower respiratory infections | Included edge-cases | Separate pathogens | |
|
Sinusitis Otitis Stomatitis (+Herpes) Catarrh Laryngitis Epiglottitis Scarlet fever Rhinoscleroma Nasopharyngitis Rhinitis (+Coryza) Diphtheria Tonsillitis Pharyngitis Supraglottitis |
Pneumonia Pseudo-Croup Pleuritis Empyema Tracheitis Bronchitis Bronchiolitis (+obstr.) Bronchopneumonia Pleuropneumonia Pertussis |
Abscesses: Mediastinal Peritonsillar Retropharyngeal Lung Influenza Mumps Measles Mononucleosis Chickenpox |
Haemophilus Measles virus Influenza virus EBV RSV Mumps virus Varicella Adenovirus Pasteurella C. diphtheriae Pneumococcus Bordetella Legionellosis Aspergillosis Blastocysts Blastomycosis Histoplasmosis Mycoplasma | |
| These interventions include strategies for outbreak prevention, any type of vaccination campaign, local health care arrangements, individual or institutional health literacy interventions pharmaceutical and non-pharmaceutical prevention and treatment strategies and housing interventions | ||||
| C | Refugees and immigrants not (yet) having had access to the respective intervention | |||
| O |
Effect of intervention measured by change of: Incidence or prevalence of respiratory infections Mortality of respiratory infections Delay to diagnosis or delay to treatment of respiratory infections Transmission and secondary case-numbers of respiratory infections | |||
| S | All controlled studies including studies with pre-test/post-test-design and non-randomised intervention studies | |||